Immune therapy of non-small cell lung cancer. The future-Reference-Cited by-同舟云学术

Immune therapy of non-small cell lung cancer. The future

Published:2015-09 Issue: Volume:99 Page:217-222
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Bobbio Antonio,Alifano Marco

Publisher

Elsevier BV

Subject

Pharmacology

Reference65 articles.

1. Surveillance, Epidemiology, and End Results (SEER) Program. SEER stat fact sheets: lung and bronchus cancer (http://www.seer.cancer.gov/statfacts/html/lungb.html).

2. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising;Devesa;Int. J. Cancer,2005

3. Cancer incidence and mortality in France over the period 1980–2005;Belot;Rev. Epidemiol. Sante Publique,2008

4. Global surveillance of cancer survival 1995–2009 analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2);Allemani;Lancet,2015

5. Annual report to the nation on the status of cancer, 1973–1996, with a special section on lung cancer and tobacco smoking;Wingo;J. Natl. Cancer Inst.,1999

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The combination of PD-L1 expression and the neutrophil-to-lymphocyte ratio as a prognostic factor of postoperative recurrence in non-small-cell lung cancer: a retrospective cohort study;BMC Cancer;2023-11-14

2. The product of PD-L1 expression and the neutrophil-to-lymphocyte ratio as a predictor of postoperative recurrence in non-small cell lung cancer: a retrospective cohort study;2023-07-17

3. Prognostic score and sex-specific nomograms to predict survival in resectable lung cancer: a French nationwide study from the Epithor cohort database;The Lancet Regional Health - Europe;2023-03

4. Non-Small Cell Carcinoma;The Thorax;2023

5. The product of the PD-L1 expression and neutrophil-to-lymphocyte ratio as a predictor of postoperative recurrence in non-small-cell lung cancer;2022-11-01